Lazure C, Gauthier D, Jean F, Boudreault A, Seidah N G, Bennett H P, Hendy G N
Laboratory of Neuropeptide Structure and Metabolism, Institut de Recherches Cliniques de Montreal (Affiliated with the University of Montreal), Montreal, Quebec H2W 1R7.
J Biol Chem. 1998 Apr 10;273(15):8572-80. doi: 10.1074/jbc.273.15.8572.
The cleavage of parathyroid hormone (PTH) from its precursor proparathyroid hormone (pro-PTH) is accomplished efficiently by the proprotein convertase furin (Hendy, G. N., Bennett, H. P. J., Gibbs, B. F., Lazure, C., Day, R., and Seidah, N. G. (1995) J. Biol. Chem. 270, 9517-9525). We also showed that a synthetic peptide comprising the -6 to +7 sequence of human pro-PTH is appropriately cleaved by purified furin in vitro. The human pro-PTH processing site Lys-Ser-Val-Lys-Lys-Arg differs from the consensus furin site Arg-Xaa-(Lys/Arg)-Arg that is represented by Arg-Arg-Leu-Lys-Arg in the cleavage site of pro-PTH-related peptide (pro-PTHrP). An earlier study demonstrated that an internally quenched fluorogenic substrate bearing an O-aminobenzoyl fluorescent donor at the NH2 terminus and an acceptor 3-nitrotyrosine near the COOH terminus was appropriately cleaved by the convertases furin and PC1 (Jean, F., Basak, A., DiMaio, J., Seidah, N. G., and Lazure, C. (1995) Biochem. J. 307, 689-695). Here, we have synthesized a series of internally quenched fluorogenic substrates based upon the pro-PTH and pro-PTHrP sequences to determine which residues are important for furin cleavage. Purified recombinant furin and PC1 cleaved the human pro-PTH internally quenched substrate at the appropriate site in an identical manner to that observed with the nonfluorescent peptide. Several substitutions in the P6-P3 sequence were well tolerated; however, replacement of the Lys at the P6 position with Gly and replacement of the P3 Lys by an acidic residue led to markedly compromised cleavage by furin. Furin activity was very sensitive to substitution in P' positions. Replacement of Ser at P1' with Gly and Val at P2' with Ala generated substrates that were less well cleaved. Substitution at the P1' position of Val for Ser in conjunction with Ala for Val at P2', as well as a single substitution of Lys for Val at P2', generated specific inhibitors of furin cleavage. The findings of this study open the way to the rational design of inhibitors of furin with therapeutic potential.
甲状旁腺激素(PTH)从前体甲状旁腺激素原(pro - PTH)的切割是由前蛋白转化酶弗林蛋白酶高效完成的(亨迪,G. N.,贝内特,H. P. J.,吉布斯,B. F.,拉祖尔,C.,戴,R.,和塞达,N. G.(1995年)《生物化学杂志》270,9517 - 9525)。我们还表明,包含人pro - PTH的 - 6至 + 7序列的合成肽在体外能被纯化的弗林蛋白酶适当地切割。人pro - PTH加工位点Lys - Ser - Val - Lys - Lys - Arg与弗林蛋白酶共有位点Arg - Xaa -(Lys/Arg)- Arg不同,后者由甲状旁腺激素相关肽(pro - PTHrP)切割位点中的Arg - Arg - Leu - Lys - Arg代表。一项早期研究表明,一种在NH₂末端带有O - 氨基苯甲酰荧光供体且在COOH末端附近带有受体3 - 硝基酪氨酸的内部淬灭荧光底物能被弗林蛋白酶和PC1适当地切割(让,F.,巴萨克,A.,迪马约,J.,塞达,N. G.,和拉祖尔,C.(1995年)《生物化学杂志》307,689 - 695)。在此,我们基于pro - PTH和pro - PTHrP序列合成了一系列内部淬灭荧光底物,以确定哪些残基对弗林蛋白酶切割很重要。纯化的重组弗林蛋白酶和PC1以与非荧光肽相同的方式在适当位点切割人pro - PTH内部淬灭底物。P6 - P3序列中的几个取代具有良好耐受性;然而,P6位置的Lys被Gly取代以及P3 Lys被酸性残基取代导致弗林蛋白酶的切割明显受损。弗林蛋白酶活性对P'位置的取代非常敏感。P1'位置的Ser被Gly取代以及P2'位置的Val被Ala取代产生的底物切割效果较差。P'位置的Val被Ser取代并结合P2'位置的Ala被Val取代,以及P2'位置的Lys被Val单取代,产生了弗林蛋白酶切割的特异性抑制剂。本研究结果为合理设计具有治疗潜力的弗林蛋白酶抑制剂开辟了道路。